SYRE
#989
Spyre Therapeutics, Inc. - Common Stock
102.0 7 USD
+0.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.15%
Changement Mensuel
+22.18%
Evolution sur 6 mois
+207.44%
Changement Annuel
+326.89%
Clôture Précédente
98.9 5
Open
102.0 7
Low
102.0 7
High
102.0 7
Volume
177
Financials
- Market Capitalization 8.86 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-23.79
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 975 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 75.82 USD | +1.03% | -5.74% | +5.88% | +13.50% | 8.99 B USD | ||
| 987 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 318.42 USD | -2.83% | -4.11% | +20.19% | +511.41% | 8.88 B USD | ||
| 990 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.90 USD | +0.23% | +0.47% | +137.95% | +104.14% | 8.85 B USD | ||
| 997 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 135.46 USD | +3.19% | -2.73% | +20.06% | +80.30% | 8.71 B USD |